SCHEMBL29119458

SCHEMBL29119458

CN1CCc2ccc(N)c([N+](=O)[O-])c2CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.56
HTR2C P28335 1/20 0.56
HTR2B P41595 1/20 0.56
SIRT6 Q8N6T7 2/20 0.41
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
ROCK1 Q13464 1/20 0.38
LMNA P02545 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2241557 0.91 HTR2A (0.50) HTR2AHTR2CHTR2BSIRT6MAPT
SCHEMBL2245425 0.80 GRIN2D (0.44) MAPTNPC1POLBRAB9ALMNA
SCHEMBL2245003 0.80 GRIN2D (0.41) MAPTPOLBRAB9ALMNAALDH1A1
SCHEMBL13006229 0.79 GRIN2D (0.40) MAPTPOLBRAB9ALMNAALDH1A1
SCHEMBL13688049 0.77 BAZ2B (0.47) HTR2AHTR2CHTR2BMAPTPOLB
SCHEMBL29119413 0.76 HTR2C (0.55) HTR2AHTR2CHTR2BSIRT6MAPT
SCHEMBL22445573 0.76 NR1H2 (0.40) HTR2AHTR2CHTR2BMAPTNPC1
SCHEMBL11331930 0.73 BAZ2B (0.43) MAPTL3MBTL1POLBLMNAALDH1A1
SCHEMBL10921359 0.72 HTR2A (1.00) HTR2AHTR2CHTR2BSIRT6MAPT
SCHEMBL4887016 0.72 MAPT (0.48) SIRT6MAPTPOLBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116888127-A Tri-fused ring HPK1 inhibitor and application thereof 轩竹生物科技股份有限公司 2023-10-13 CN disclosed
WO-2022188823-A1 TRICYCLIC HPK1 INHIBITOR AND USE THEREOF 山东轩竹医药科技有限公司 2022-09-15 WO disclosed